ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1127

Mass Spectrometry Imaging Revealed Potential Lipid Chondrogenic Biomarkers for Cell-Based Therapy in Cartilage

Beatriz Rocha1, Berta Cillero-Pastor2, Gert Eijkel2, Valentina Calamia1, Lucia Lourido1, Carolina Fernández-Costa1, Patricia Fernandez-Puente1, Jesus Mateos1, Cristina Ruiz-Romero1,3, Ron MA Heeren2 and Francisco J. Blanco Garcia1, 1Grupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006., A Coruña, Spain, 21Biomolecular Imaging Mass Spectrometry (BIMS) Molecular Nanophotonics Department, AMOLF, Amsterdam, Netherlands, 3CIBER-BBN, INIBIC-CHUAC, A Coruña, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, cartilage, lipids and mesenchymal stem cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics, Genomics and Proteomics II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recent studies highlight the importance of lipid metabolism in the modulation of chondrogenesis. Specifically, the positive chondrogenic effect of acid ceramidase, which is necessary to maintain the metabolic balance of several bioactive lipids, during the chondrogenesis of mesenchymal stem cells (MSCs) has been demonstrated. Therefore, knowledge on the distribution and modulation of lipids during chondrogenesis could be highly valuable to improve MSC-based cartilage therapies by the discovery of new chondrogenic markers. In this work, mass spectrometry imaging (MSI) has been employed to characterize the spatial distribution of lipids in human bone marrow MSCs (hBMSCs) during the first steps of their chondrogenic differentiation.

Methods: hBMSCs micromasses obtained from 3 osteoarthritic donors and collected at day 2 and 14 of chondrogenesis were gelatin-embedded and cryo-sectioned into thin sections for MSI. Samples were then sprayed with matrix and analyzed by matrix-assisted laser desorption ionization (MALDI)-MSI to obtain the lipid profiles. Statistical methods such as PCA and discriminant analysis were used for data interpretation. Lipid images were generated with Biomap software. Data were confirmed by Real-Time PCR analyses.

Results: Analysis of hBMSCs micromasses at days 2 and 14 of chondrogenesis by MALDI-MSI led to the identification of 20 different intact lipid species, including fatty acids, sphingolipids and phospholipids (Table 1). Among the lipid classes identified, we found phosphatidylcholines and sphingomyelins levels decreased during chondrogenic differentiation (Figure 1). These data suggest that hBMSCs mobilize the SMs in order to produce secondary metabolites such as sphingosine-1-phosphate and ceramides that are necessary for their differentiation towards chondrocytes. In addition, a clear up-regulation of 4.74-fold was found for sphingosine kinase 1 (p<0.05) at day 14 when compared to day 2, supporting the low expression of SMs intact species at day 14 of chondrogenesis.

Conclusion: The data compiled herein are undoubtedly useful for a better understanding of the molecular processes that occur during the differentiation of these cells towards cartilage-like tissues. In addition, the differential lipid profiles described in our study might serve as useful differentiation markers for the development of cell-based therapies for cartilage repair. In fact, the loss of SM during chondrogenesis might be used as a novel chondrogenic marker.

Table 1.jpg

Figure1_mod.jpg


Disclosure:

B. Rocha,
None;

B. Cillero-Pastor,
None;

G. Eijkel,
None;

V. Calamia,
None;

L. Lourido,
None;

C. Fernández-Costa,
None;

P. Fernandez-Puente,
None;

J. Mateos,
None;

C. Ruiz-Romero,
None;

R. M. Heeren,
None;

F. J. Blanco Garcia,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mass-spectrometry-imaging-revealed-potential-lipid-chondrogenic-biomarkers-for-cell-based-therapy-in-cartilage/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology